HOME >> MEDICINE >> NEWS
Highest sustained virologic response in treatment of Hepatitis C ever reported in prospective study

A combination treatment of Pegasys (peginterferon alfa-2a 40kd) a pegylated interferon, with ribavirin, an orally active anti-viral medication, has shown some of the most effective treatment rates yet for individuals with hepatitis C. The combination treatment yielded a 61 percent sustained virologic response (SVR), the highest SVR ever reported in a prospective trial for a pegylated interferon using an intent-to-treat (ITT) analysis, according to Dr. Donald Jensen at Rush-Presbyterian-St. Luke's Medical Center.

SVR refers to a patient's continued undetectable serum hepatitis C (HCV) RNA levels six months after discontinuation of treatment. Results of a recently completed phase III study of the investigational hepatitis C therapy were presented today at the European Association for the Study of Liver (EASL) annual meeting in Madrid, Spain.

The study also revealed strong evidence that, to achieve optimal results, treatment regimens should be based on hepatitis C virus genotype, rather than on the traditional, weight-based methodology.

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis and liver cancer. It is also the primary reason for liver transplantation in the United States. An estimated 2.7 million Americans are chronically infected with the virus, with about 35,000 new infections reported each year.

"These results are unprecedented," explained Jensen, a U.S. investigator in the trial and director of Hepatology at Rush-Presbyterian St. Luke's Medical Center, Chicago. "Physicians can confidently expect that when Pegasys is available they can prescribe it for the most appropriate length and dose of combination treatment based on a patient's genotype and achieve optimal results." Rush-Presbyterian St. Luke's Medical Center was one of 29 U.S. trial locations.

The study also found a 51 percent SVR, the highest ever achieved, for patients with genotype 1, the most difficu
'"/>

Contact: John M. Pontarelli
jpontare@rsh.net
312-942-5949
Rush University Medical Center
18-Apr-2002


Page: 1 2 3

Related medicine news :

1. Highest average rate of US road deaths on Independence Day
2. Highest known catalytic rate for superoxide dismutation achieved
3. Patients May Not Be Receiving The Highest Quality Of Care
4. Acute Urinary Retention And BPH-Related Surgery: Predicting Those At Highest Risk And Prevention With Finasteride
5. Chemical Societys Highest Award Goes To Ronald Breslow
6. The sustained benefits of very early treatment of rheumatoid arthritis with anti-TNF-alpha therapy
7. Non-drug treatment device delivers sustained blood pressure reductions within 3-4 weeks in the home
8. New study demonstrates significant and sustained improvements in BPH symptoms with AVODART ™
9. Children achieve sustained ADHD symptom improvement with long-term, once-daily use of Adderall XR
10. New data show fast and significant weight loss with Xenical sustained over time
11. New data shows rapid and sustained weight loss with Xenical

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Lisa Vuich MD ... for Specialty MED Training will take the stage during the 26th World ... 2019. Dr. Vuich is leading a CME workshop hosted by Tailor Made Compounding ...
(Date:11/14/2018)... ... 14, 2018 , ... Entrepreneur Media, Inc., publisher of Entrepreneur ... power its "Ask an Expert" online mentor marketplace. The program aims to connect ... virtual sessions that are focused on starting and growing a business, building a ...
(Date:11/14/2018)... ... November 14, 2018 , ... “The Health ... 1, 2018 and continues through Dec. 15, 2018). Enrolling in the Marketplace can ... not have to be an overwhelming process,” explained Bob Dial, Chief Compliance Officer, ...
(Date:11/13/2018)... MINNEAPOLIS (PRWEB) , ... November 13, 2018 , ... People ... affiliation with the 10th Annual Give to the Max Day slated for Thursday, November ... a part of Give to the Max Day. , Give to the Max ...
(Date:11/13/2018)... ... 2018 , ... A recent public health advisory from the ... overdose reversal drug. Most states, including California, have legislation or protocols in place ... A new study by faculty at the Keck Graduate Institute (KGI) ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... ... Triple W, an innovator of connected health devices, today announced the availability ... the first wearable device for incontinence that notifies the user when it’s time to ... bladder control issues have a convenient and cost-effective alternative to disposable diapers or pads ...
(Date:11/15/2018)... Texas (PRWEB) , ... November ... ... announced the acquisition of Metamorphosis, an Opioid Treatment Program (OTP) with locations ... treatment since 1995, Metamorphosis has established themselves as a high-quality, trusted provider ...
(Date:11/15/2018)... ... 15, 2018 , ... This exclusive ranking is a reflection ... forward. The award, known as the Omni500, represents the most unique class of ... among the communities they serve.2018 marks OMNIKAL’S 18th annual listing of the Nation’s ...
Breaking Medicine Technology:
Cached News: